ZoMedica Pharmaceuticals
OTC: ZOMDFAnn Arbor, US · Founded 2015 · Alberta, Canada corporation
Founders & leadership
ZoMedica Pharmaceuticals was founded in 2015 by Jerry Solensky.
JS
Jerry SolenskyinFounderJerry Solensky is Chief Executive Officer and Director of ZoMedica Pharmaceuticals, with background in finance, sales, marketing, business development, and capital markets, as well as over 800 observation hours in pre-veterinary medicine.
WM
William MacArthurExecutive
SM
Stephanie MorleyExecutive
SR
Shameze RampertabExecutive
Board
JL
Jim LebarBoard director
JR
Jeffrey RoweBoard director
RJ
Rodney J. WilliamsBoard director
Reported raises · per SEC filings
Form D private placements$28.5M disclosed across 8 of 9 rounds · 2015–2020
▶Undisclosed amountofferedFeb 2020 · 2 investors · Other Health CareRule 506(b)
▶Undisclosed amountofferedFeb 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Johnny D. PowersDirector
- Bruk HerbstExecutive Officer
- James LeBarDirector
- Rodney J. WilliamsDirector
- Shameze RampertabExecutive Officer, Director
- Jeffrey RoweDirector
- Stephanie MorleyExecutive Officer
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Feb 2020
- Incorporated
- Corporation, Alberta, Canada
- Federal exemptions
- 06b
▶$12MraisedMay 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$12MraisedMay 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rodney J. WilliamsDirector
- Jeffrey RoweDirector
- Shameze RampertabExecutive Officer, Director
- Stephanie MorleyExecutive Officer
- James LeBarDirector
- Bruk HerbstExecutive Officer
- Gerald SolenskyExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- May 2019
- Incorporated
- Corporation, Alberta, Canada
- Federal exemptions
- 06b
▶$550KraisedMay 2018 · 3 investors · PharmaceuticalsRule 506(b)
▶$550KraisedMay 2018 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerald SolenskyExecutive Officer, Director
- Stephanie MorleyExecutive Officer
- Bruk HerbstExecutive Officer
- James Le BarDirector
- Jane EaglesonDirector
- Robert DiMarzoExecutive Officer
- Jeffrey RoweDirector
- Shameze RampertabExecutive Officer, Director
- Thomas RobitailleDirector
- Rodney J. WilliamsDirector
- Offering amount
- $10M
- Amount sold
- $550K
- First sale
- May 2018
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
▶$1.3MraisedMay 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedMay 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephanie MorleyExecutive Officer
- Shameze RampertabExecutive Officer, Director
- Bruk HerbstExecutive Officer
- Thomas RobitailleDirector
- Robert DiMarzoExecutive Officer
- Jane EaglesonDirector
- Jeffrey RoweDirector
- James Le BarDirector
- Gerald SolenskyExecutive Officer, Director
- Rodney J. WilliamsDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- May 2018
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
▶$3.3MraisedAug 2017 · 3 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedAug 2017 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert DiMarzoExecutive Officer
- Shameze RampertabExecutive Officer, Director
- Tom RobitailleDirector
- Jeffrey RoweDirector
- Jane EaglesonDirector
- Gerald SolenskyExecutive Officer, Director
- Rodney J. WilliamsDirector
- Bruk HerbstExecutive Officer
- Stephanie MorleyExecutive Officer
- Jim LebarDirector
- Offering amount
- $10.1M
- Amount sold
- $3.3M
- First sale
- Jul 2017
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
▶$866KraisedJan 2017 · 3 investors · PharmaceuticalsRule 506(b)
▶$866KraisedJan 2017 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Tom RobitailleDirector
- Jim LebarDirector
- Gerald SolenskyExecutive Officer, Director
- Rodney J. WilliamsDirector
- Shameze RampertabExecutive Officer, Director
- Jane EaglesonDirector
- Jeffrey RoweDirector
- William MacArthurExecutive Officer, Director
- Stephanie MorleyExecutive Officer
- Offering amount
- $7.4M
- Amount sold
- $866K
- First sale
- Dec 2016
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
▶$3.7MraisedJan 2017 · 20 investors · PharmaceuticalsRule 506(b)
▶$3.7MraisedJan 2017 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William MacArthurExecutive Officer, Director
- Rodney J. WilliamsDirector
- Jim LebarDirector
- Stephanie MorleyExecutive Officer
- Jeffrey RoweDirector
- Shameze RampertabExecutive Officer, Director
- Jane EaglesonDirector
- Tom RobitailleDirector
- Gerald SolenskyExecutive Officer, Director
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- Dec 2016
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
▶$3.9MraisedSep 2016 · 20 investors · PharmaceuticalsRule 506(b)
▶$3.9MraisedSep 2016 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey RoweDirector
- William MacArthurExecutive Officer, Director
- Jim LebarDirector
- Gerald SolenskyExecutive Officer, Director
- Stephanie MorleyExecutive Officer
- Shameze RampertabExecutive Officer, Director
- Rodney J. WilliamsDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- Aug 2016
- Incorporated
- Corporation, Alberta, Canada, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ZoMedica Pharmaceuticals?
- ZoMedica Pharmaceuticals was founded by Jerry Solensky in 2015.
- How much funding has ZoMedica Pharmaceuticals raised?
- ZoMedica Pharmaceuticals has disclosed $28.5M raised across 8 of its 9 known rounds.
- Where is ZoMedica Pharmaceuticals headquartered?
- ZoMedica Pharmaceuticals is headquartered in Ann Arbor, US.